Detecting kidney DNA to spot organ rejection early
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have at least one working kidney transplant.
- You are scheduled for a kidney biopsy because of a possible problem.
- You are being seen at Pitié Salpêtrière or Necker Hospital.
- You have health insurance through the French social security system (not AME).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
This trial tests a blood test that may help monitor kidney transplant health by detecting signs of rejection earlier. It aims to see if using this blood test can lead to better long-term outcomes for transplant recipients.
This study collects blood and leftover donor samples from kidney transplant recipients who need a biopsy. The goal is to improve monitoring after transplant.
This study tests a blood test called GraftAssure that may help doctors detect if your body is rejecting your new kidney. By monitoring this, the test could help prevent kidney damage and improve transplant outcomes.
This study looks for small pieces of kidney DNA in the blood of kidney transplant patients. It aims to improve monitoring of transplant health.
This study is for people with a kidney transplant who are in the hospital for a biopsy because their doctor suspects rejection. Researchers want to see if a simple blood or urine test can detect rejection, which might make future biopsies less necessary.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.